🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Howard University College of Pharmacy is looking for a pharmacy faculty member specifically in the area of Cardiology or Critical Care! Come work in DC at HUCOP! linkedin.com/jobs/view/4149…

Check it out-IDSA draft Complicated UTI guidelines are up for public comments! These guidelines represent the work of 19 multidiciplinary panelists with input from 15+ professional societies idsociety.org/practice-guide…

"Disruptions in the workforce, even brief, can have far reaching consequences,” says IDSA member Josh Barocas, MD. Our press briefing explores the impact of disruptions in public health information: idsociety.org/multimedia/vid…

The GLP-1 receptor agonists (like Ozempic and Mounjaro) are wildly effective weight-loss agents. But are they COST-effective? That's a trickier question. And a new study just out in JAMA Health Forum provides an answer. A resounding "no." (Thread)

Residency Life Hacks: Assisting in your first lumbar puncture and not sure of all the steps? Don’t fret! NEJM Videos in Clinical Medicine has you covered. Watch "Lumbar Puncture" and explore more than 100 useful videos explaining common procedures: nej.md/lumbar-puncture

List of #IDtwitter PGY2 #TwitteRX Phase 2 residencies. Amazing programs. natmatch.com/ashprmp/direct…

New #LetsTalkID out now! Paul Sax speaks w/ Vidya Sundareshan, MD & Alfredo Mena Lora, MD, FIDSA on how international medical graduates (IMGs) can pursue a career in ID, including visa options & job search strategies. Available in all apps. Transcript: bit.ly/422pfbn

What really happens when patients stop GLP-1s like semaglutide or tirzepatide? A new systematic review & meta-analysis in Obesity Reviews has answers—and they’re critical for anyone treating obesity as a chronic disease. TLDR: "Discontinuation of GLP-1RA treatment leads to

The most anticipated RCT in ID 🔥SNAP RCT🔥The largest RCT 2 date in SA bactermia N:1341 Cefazolin Vs ASPs ((flu)cloxacillin) for MSSA bacteremia Cefazolin is non-inferior (90d mortality)& less AKI than ASPs A practice-changer RCT that must change the guidelines #ESCMIDGlobal

Complicated UTI. Glad that I’m not the only one confused on the definition. #ESCMIDGlobal2025

Wow. The Trump administration’s proposed FY2026 budget calls for a 1/3 cut to HHS and a 40% cut to NIH - with an unprecedented reduction in funding from $47B to $27B and collapsing 27 institutes into 8. More below.

The CDC would be cut by 44%, from $9.2B to $5.2B. Chronic disease programs, including heart disease, diabetes, obesity, and smoking cessation, would be eliminated. The agency’s domestic HIV response would also be shut down.

🔥 Just published 🔥 World Health Organization (WHO) consolidated guidelines on tuberculosis(TB) : module 4: treatment and care #IDXposts Thanks ahmad hafizi who.int/publications/i…

In 2000, measles was declared eliminated in the US. Not a single case in 12 months, largely due to successful vaccination campaigns. And here we are.

🔥 JAMA Internal Medicine RCT of EM PharmD-led TOC program 💊 330 pts to ED w/ med-related events (MRE) w/ or w/o EMP TOC @ 72h 💊EMP group⬇️ ED visits for same MRE (3% v 22%) & overall ED visits, ⬇️ hospitalizations, more outpatient follow up LOVE to see it! jamanetwork.com/journals/jamai…

🆕💫New Hope, New Threat: Ceftazidime/avibactam brought promise—resistance followed fast. England’s 4-year data shows why real-time surveillance and stewardship matter more than ever. A must-read Eurosurveillance #IDXposts pmc.ncbi.nlm.nih.gov/articles/PMC11…

It is really weird that we have collectively chosen to memory hole this fact.

the reconciliation bill eliminates grad plus loans which allow grad students to cover the full cost of their attendance. probably will destroy law school, medical schools, and most graduate programs everywhere in the country

The 17 fired members of ACIP, including me, have written an article in JAMA about our experience and our concerns. jamanetwork.com/journals/jama/…

BREAKING: MIT just completed the first brain scan study of ChatGPT users & the results are terrifying. Turns out, AI isn't making us more productive. It's making us cognitively bankrupt. Here's what 4 months of data revealed: (hint: we've been measuring productivity all wrong)